Alembic Pharmaceuticals discloses demise of Resident Director Mr. Saibal Mukherjee on April 26, 2026.
The disclosure is made under SEBI Listing Regulations 30 requirements with formal notification to BSE and NSE.
Mr. Mukherjee joined the company in 2014 and was described as an integral part of the organization.
The company expresses deep sympathy and condolences to his family, noting an irreparable loss.